Header Logo

Connection

RADEK SKODA to Receptor, Platelet-Derived Growth Factor beta

Back to Details
This is a "connection" page, showing publications RADEK SKODA has written about Receptor, Platelet-Derived Growth Factor beta.
RADEK SKODA
Connection Strength
0.060
Receptor, Platelet-Derived Growth Factor beta
  1. Targeting compensatory MEK/ERK activation increases JAK inhibitor efficacy in myeloproliferative neoplasms. J Clin Invest. 2019 03 04; 129(4):1596-1611.
    View in: PubMed
    Score: 0.039
  2. Myeloproliferative neoplasms: contemporary diagnosis using histology and genetics. Nat Rev Clin Oncol. 2009 Nov; 6(11):627-37.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.